TRVI Trevi Therapeutics
- 4.030
- -0.040-0.98%
- 4.030
- 0.0000.00%
Trevi Therapeutics News
Trevi Therapeutics | 8-K: Current report
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Galletta Christopher
Trevi Therapeutics | 8-K: Current report
Trevi Therapeutics | 424B5: Prospectus
Trevi Therapeutics | 8-K: Current report
Trevi Therapeutics | 8-K: Current report
Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners II, L.P.(9.99%),VHCP Co-Investment Holdings II, LLC(9.99%), etc.
Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(6.92%),David Rosen(6.92%)
Trevi Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-New Enterprise Associates 16, L.P.(18.7%),NEA Partners 16, L.P.(18.7%), etc.
Trevi Therapeutics | 10-Q: Q3 2024 Earnings Report
Trevi Therapeutics | 8-K: Trevi Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James N. Topper(10.2%),Patrick J. Heron(10.2%), etc.
Trevi Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rosalind Advisors, Inc.(1.03%),Steven Salamon(1.03%), etc.
Trevi Therapeutics | 8-K: Current report
Trevi Therapeutics | 8-K: Current report
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cassella James V
Trevi Therapeutics | 8-K: Current report
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GOOD JENNIFER L
Trevi Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GOOD JENNIFER L
Trevi Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
No Data